LONDON--(BUSINESS WIRE)--The worldwide hematology and flow cytometry markets are poised to undergo a significant transformation during the next decade. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-use laser systems will further expand applications of flow cytometry to daily clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit the development of various advanced features. Currently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more machine aided and routine.
New market research report “Innovative Hematology and Flow Cytometry Technologies and Emerging Markets” created by Venture Planning Group is designed to identify and evaluate emerging opportunities in the global hematology and flow cytometry markets during the next decade.
The report explores future marketing and technological trends in the key countries – France, Germany, Italy, Japan, Spain, the UK and the US. It also provides sales and market shares of reagent and instrument suppliers, specimen forecasts by market segment, test volume forecasts by assay and market segment, instrument placements and installed base by manufacturer and model. The comparison of features of over 60 analyzers is included. The profiles of the top competitors and emerging market entrants, as well as reviews of specific product and marketing opportunities facing suppliers are also within the focus of the market analysis.
Title: Innovative Hematology and Flow Cytometry Technologies and Emerging Markets
Published: November, 2012
Price: US$ 28,400.00
More In-Vitro Diagnostics Market Research Reports by VPG are Also Available:
- Innovative Coagulation Testing Technologies and Emerging Markets
- Innovative Molecular Diagnostic Technologies and Emerging Markets
- Innovative Clinical Chemistry and Immunodiagnostic Technologies and Emerging Markets
- Innovative Cancer Diagnostic Technologies and Emerging Markets
- Innovative Infectious Disease Testing Technologies and Emerging Markets
More new market research reports by VPG can be found at http://marketpublishers.com/members/vpg/info.html